Susquehanna International Group’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-581,140
| Closed | -$26.9M | – | 5339 |
|
2019
Q2 | $26.9M | Buy |
+581,140
| New | +$26.9M | 0.01% | 192 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 5220 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5395 |
|
2018
Q3 | – | Sell |
-306,944
| Closed | -$5.15M | – | 5307 |
|
2018
Q2 | $5.15M | Buy |
+306,944
| New | +$5.15M | ﹤0.01% | 582 |
|
2018
Q1 | – | Sell |
-520,780
| Closed | -$6.67M | – | 5070 |
|
2017
Q4 | $6.67M | Sell |
520,780
-118,774
| -19% | -$1.52M | ﹤0.01% | 460 |
|
2017
Q3 | $7.87M | Buy |
639,554
+283,202
| +79% | +$3.48M | ﹤0.01% | 374 |
|
2017
Q2 | $2.98M | Buy |
356,352
+203,917
| +134% | +$1.71M | ﹤0.01% | 853 |
|
2017
Q1 | $1.36M | Sell |
152,435
-274,906
| -64% | -$2.46M | ﹤0.01% | 1380 |
|
2016
Q4 | $3.76M | Buy |
427,341
+396,861
| +1,302% | +$3.49M | ﹤0.01% | 849 |
|
2016
Q3 | $206K | Sell |
30,480
-307,930
| -91% | -$2.08M | ﹤0.01% | 2560 |
|
2016
Q2 | $1.21M | Buy |
+338,410
| New | +$1.21M | ﹤0.01% | 1438 |
|
2016
Q1 | – | Sell |
-35,158
| Closed | -$149K | – | 4679 |
|
2015
Q4 | $149K | Sell |
35,158
-190,148
| -84% | -$806K | ﹤0.01% | 3848 |
|
2015
Q3 | $1.03M | Buy |
225,306
+180,531
| +403% | +$823K | ﹤0.01% | 2398 |
|
2015
Q2 | $323K | Buy |
44,775
+19,757
| +79% | +$143K | ﹤0.01% | 3717 |
|
2015
Q1 | $184K | Sell |
25,018
-551,770
| -96% | -$4.06M | ﹤0.01% | 3764 |
|
2014
Q4 | $2.73M | Buy |
576,788
+363,333
| +170% | +$1.72M | ﹤0.01% | 1554 |
|
2014
Q3 | $762K | Buy |
213,455
+4,739
| +2% | +$16.9K | ﹤0.01% | 2608 |
|
2014
Q2 | $952K | Sell |
208,716
-362,240
| -63% | -$1.65M | ﹤0.01% | 2483 |
|
2014
Q1 | $2.68M | Buy |
570,956
+74,742
| +15% | +$351K | ﹤0.01% | 1328 |
|
2013
Q4 | $2.49M | Buy |
496,214
+364,438
| +277% | +$1.83M | ﹤0.01% | 1462 |
|
2013
Q3 | $819K | Buy |
131,776
+51,419
| +64% | +$320K | ﹤0.01% | 2257 |
|
2013
Q2 | $365K | Buy |
+80,357
| New | +$365K | ﹤0.01% | 2742 |
|